In humans, the level of anti-DSG2 antibodies correlated with the burden of premature ventricular contractions; In vitro, the antibodies caused gap junction dysfunction, which was a common feature of ARVC. This evidence concerns the gene DSG2 and arrhythmogenic right ventricular cardiomyopathy.